ORBIMED ADVISORS LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$5.4B
Holdings
129
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (129 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SVASINOVAC BIOTECH LTD | 2,718,735 | $340.5B | 6320.77% | |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 2,584,900 | $183.8B | 3411.19% | |
| 3 | HUMHUMANA INC | 348,700 | $169.2B | 3140.63% | |
| 4 | SWTXSPRINGWORKS THERAPEUTICS INC | 5,525,926 | $157.7B | 2926.58% | |
| 5 | BSXBOSTON SCIENTIFIC CORP | 3,898,200 | $151.0B | 2802.62% | |
| 6 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,717,310 | $145.6B | 2702.36% | |
| 7 | EWTXEDGEWISE THERAPEUTICS INC | 14,567,176 | $143.3B | 2660.87% | |
| 8 | UNHUNITEDHEALTH GROUP INC | 267,200 | $134.9B | 2505.05% | |
| 9 | PFEPFIZER INC | 2,599,000 | $113.7B | 2111.23% | |
| 10 | THRDTHIRD HARMONIC BIO INC | 5,779,071 | $109.6B | 2035.07% | |
| 11 | VRTXVERTEX PHARMACEUTICALS INC | 373,200 | $108.1B | 2005.87% | |
| 12 | SGENUSDSEAGEN INC | 787,600 | $107.8B | 2000.52% | Call |
| 13 | 1T7TRICIDA INC | 10,280,947 | $107.7B | 2000.07% | |
| 14 | ISRGINTUITIVE SURGICAL INC | 572,700 | $107.3B | 1992.70% | |
| 15 | TORCEURADICET BIO INC | 7,447,140 | $105.9B | 1965.81% | |
| 16 | TMOTHERMO FISHER SCIENTIFIC INC | 202,200 | $102.6B | 1903.73% | |
| 17 | SRPTSAREPTA THERAPEUTICS INC | 918,500 | $101.5B | 1884.74% | |
| 18 | MRTXEURMIRATI THERAPEUTICS INC | 1,418,892 | $99.1B | 1839.52% | |
| 19 | —THESEUS PHARMACEUTICALS INC | 17,041,668 | $98.8B | 1834.82% | |
| 20 | NBIXNEUROCRINE BIOSCIENCES INC | 896,545 | $95.2B | 1767.63% | |
| 21 | ARGXARGENX SE | 269,700 | $95.2B | 1767.55% | |
| 22 | SYKSTRYKER CORPORATION | 423,100 | $85.7B | 1590.77% | |
| 23 | ABBVABBVIE INC | 600,000 | $80.5B | 1494.82% | |
| 24 | EWEDWARDS LIFESCIENCES CORP | 966,300 | $79.8B | 1482.18% | |
| 25 | PMVPPMV PHARMACEUTICALS INC | 6,563,077 | $78.1B | 1449.81% | |
| 26 | EVHEVOLENT HEALTH INC | 1,994,717 | $71.7B | 1330.43% | |
| 27 | PRLDPRELUDE THERAPEUTICS INC | 10,039,691 | $66.4B | 1231.89% | |
| 28 | NTRANATERA INC | 1,505,153 | $66.0B | 1224.35% | |
| 29 | KROSKEROS THERAPEUTICS INC | 1,679,417 | $63.2B | 1172.82% | |
| 30 | CRNXCRINETICS PHARMACEUTICALS IN | 3,196,876 | $62.8B | 1165.53% | |
| 31 | —MERSANA THERAPEUTICS INC | 9,011,437 | $60.9B | 1130.81% | |
| 32 | BIIBBIOGEN INC | 224,600 | $60.0B | 1113.20% | |
| 33 | SIBNSI-BONE INC | 3,368,000 | $58.8B | 1091.61% | |
| 34 | VRNAVERONA PHARMA PLC | 5,694,841 | $58.2B | 1080.40% | |
| 35 | ARQTARCUTIS BIOTHERAPEUTICS INC | 2,800,000 | $53.5B | 993.28% | |
| 36 | GHGUARDANT HEALTH INC | 992,400 | $53.4B | 991.67% | |
| 37 | XTNTXTANT MED HLDGS INC | 73,114,592 | $52.6B | 976.94% | |
| 38 | ALNYALNYLAM PHARMACEUTICALS INC | 250,500 | $50.1B | 930.76% | |
| 39 | CMPXCOMPASS THERAPEUTICS INC | 21,960,850 | $50.1B | 929.48% | |
| 40 | BLUBELLUS HEALTH INC NEW | 4,634,900 | $49.0B | 909.06% | |
| 41 | —KINNATE BIOPHARMA INC | 4,043,629 | $48.3B | 896.99% | |
| 42 | SNDXSYNDAX PHARMACEUTICALS INC | 2,006,500 | $48.2B | 895.04% | |
| 43 | SPRYSILVERBACK THERAPEUTICS INC | 8,740,887 | $46.2B | 856.73% | |
| 44 | TERNTERNS PHARMACEUTICALS INC | 7,481,204 | $44.1B | 817.97% | |
| 45 | ACRSACLARIS THERAPEUTICS INC | 2,758,434 | $43.4B | 805.98% | |
| 46 | PGNYPROGYNY INC | 1,134,053 | $42.0B | 780.17% | |
| 47 | ABCLABCELLERA BIOLOGICS INC | 4,180,768 | $41.3B | 767.55% | |
| 48 | XENEXENON PHARMACEUTICALS INC | 1,137,300 | $41.1B | 762.15% | |
| 49 | RPTXREPARE THERAPEUTICS INC | 3,322,488 | $40.3B | 748.13% | |
| 50 | 290ACHINOOK THERAPEUTICS INC | 2,029,300 | $39.9B | 740.60% | |
| 51 | —VECTIVBIO HLDG AG | 6,473,561 | $38.8B | 721.01% | |
| 52 | JANXJANUX THERAPEUTICS INC | 2,836,386 | $38.4B | 712.92% | |
| 53 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $37.5B | 696.97% | |
| 54 | ISIIONIS PHARMACEUTICALS INC | 768,900 | $34.0B | 631.30% | |
| 55 | THCTENET HEALTHCARE CORP | 643,300 | $33.2B | 615.95% | |
| 56 | SCPHSCPHARMACEUTICALS INC | 4,797,148 | $31.3B | 580.60% | |
| 57 | TVTXTRAVERE THERAPEUTICS INC | 1,253,130 | $30.9B | 573.18% | |
| 58 | RAPTEURRAPT THERAPEUTICS INC | 1,251,070 | $30.1B | 558.77% | |
| 59 | QUREUNIQURE NV | 1,597,000 | $30.0B | 556.15% | |
| 60 | NVLSEURALPINE IMMUNE SCIENCES INC | 4,081,592 | $29.4B | 545.52% | |
| 61 | ALXOALX ONCOLOGY HLDGS INC | 2,871,000 | $27.5B | 510.02% | |
| 62 | —BIOHAVEN PHARMACTL HLDG CO L | 170,769 | $25.8B | 479.21% | |
| 63 | TELATELA BIO INC | 3,027,542 | $25.8B | 478.84% | |
| 64 | GRCLGRACELL BIOTECHNOLOGIES INC | 7,884,870 | $25.4B | 471.30% | |
| 65 | PCVXVAXCYTE INC | 967,900 | $23.2B | 431.22% | Call |
| 66 | IMAIKENA ONCOLOGY INC | 6,467,691 | $23.0B | 426.21% | |
| 67 | ETNBGBP89BIO INC | 3,658,869 | $21.2B | 393.26% | |
| 68 | IOVAIOVANCE BIOTHERAPEUTICS INC | 2,007,458 | $19.2B | 356.99% | |
| 69 | GHRSGH RESEARCH PLC | 1,622,060 | $18.8B | 349.88% | |
| 70 | MGTXMEIRAGTX HLDGS PLC | 2,108,143 | $17.7B | 329.11% | |
| 71 | —DECIBEL THERAPEUTICS INC | 4,945,192 | $17.1B | 317.62% | |
| 72 | IVVDINVIVYD INC | 5,270,400 | $16.5B | 306.22% | |
| 73 | KZRKEZAR LIFE SCIENCES INC | 1,771,700 | $15.3B | 283.16% | |
| 74 | TSVT*2SEVENTY BIO INC | 1,041,300 | $15.2B | 281.25% | |
| 75 | KALVKALVISTA PHARMACEUTICALS INC | 1,042,000 | $15.1B | 280.66% | |
| 76 | NPCENEUROPACE INC | 4,012,281 | $15.0B | 279.30% | |
| 77 | VSTMVERASTEM INC | 17,200,000 | $14.6B | 271.39% | |
| 78 | RXSTRXSIGHT INC | 1,202,833 | $14.4B | 267.94% | |
| 79 | AVTEAEROVATE THERAPEUTICS INC | 795,000 | $13.2B | 244.68% | |
| 80 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 30,000,000 | $12.5B | 232.21% | |
| 81 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 20,000,000 | $11.8B | 218.30% | |
| 82 | PASGPASSAGE BIO INC | 8,931,999 | $11.2B | 207.26% | |
| 83 | MIRMMIRUM PHARMACEUTICALS INC | 521,891 | $11.0B | 203.55% | |
| 84 | —IKENA ONCOLOGY INC | 2,933,941 | $10.4B | 193.34% | |
| 85 | —CINCOR PHARMA INC | 314,202 | $10.3B | 191.42% | |
| 86 | —IMARA INC | 4,386,568 | $10.0B | 185.65% | |
| 87 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $9.7B | 180.19% | |
| 88 | —GEMINI THERAPEUTICS INC | 5,826,223 | $9.6B | 177.37% | |
| 89 | MREOMEREO BIOPHARMA GROUP PLC | 10,605,522 | $9.1B | 169.52% | |
| 90 | ASNSUSDX4 PHARMACEUTICALS INC | 5,026,817 | $8.6B | 159.57% | |
| 91 | CGEMCULLINAN ONCOLOGY INC | 637,287 | $8.2B | 151.66% | |
| 92 | RCUSARCUS BIOSCIENCES INC | 303,000 | $7.9B | 147.13% | |
| 93 | VTYXVENTYX BIOSCIENCES INC | 225,000 | $7.9B | 145.81% | |
| 94 | GLTOUSDGALECTO INC | 4,090,937 | $7.7B | 143.53% | |
| 95 | EYPTEYEPOINT PHARMACEUTICALS INC | 970,860 | $7.7B | 142.57% | |
| 96 | NXTCNEXTCURE INC | 2,711,013 | $7.5B | 138.39% | |
| 97 | LUNGPULMONX CORP | 435,000 | $7.2B | 134.53% | |
| 98 | JNCEEURJOUNCE THERAPEUTICS INC | 2,928,900 | $6.9B | 127.23% | |
| 99 | ORICORIC PHARMACEUTICALS INC | 2,087,568 | $6.7B | 124.00% | |
| 100 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,578,174 | $6.4B | 119.18% |
Page 1 of 2Next